To evaluate the efficacy of oral administration of Huoxiangzhengqi pill and moxibustion therapy in postoperative esophageal cancer patients with functional diarrhea, so as to provide a theoretical basis for clinical treatment and nursing care.

A total of 135 patients with postoperative functional diarrhea were enrolled in this study from October 2014 to April 2016. Patients were randomly divided into three groups: the Huoxiangzhengqi pill group, the moxibustion care group and the combination therapy group (at the same time to give oral Huoxiangzhengqi pills and moxibustion care operation), each group of 45 cases, the clinical efficacy and body mass index (BMI) of the three groups were compared.

The total effective rate was 68.9% in the Huoxiangzhengqi pill group and 71.1% in the moxibustion care group. The total effective rate was 91.1% in the combination therapy group. The total effective rate of treatment in the combination therapy group was significantly higher than the Huoxiangzhengqi pill group and the moxibustion care group (P<0.05). After treatment, the body mass index (BMI) of the patients in the combination therapy group was significantly higher than the Huoxiangzhengqi pill group and the moxibustion care group (t=-8.38, P<0.01).

Combined use of oral administration of Huoxiangzhengqi pill and moxibustion nursing operation has synergistic effect on patients with functional diarrhea after esophageal cancer surgery. It is worthy of recommendation.